Published on in Vol 10, No 4 (2021): April
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/24731, first published
.
Journals
- Dezanet L, Miailhes P, Lascoux‐Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Profiles of liver fibrosis evolution during long‐term tenofovir treatment in HIV‐positive patients coinfected with hepatitis B. Liver International 2021;41(12):2874 View
- Dezanet L, Kassime R, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Clinical Infectious Diseases 2022;74(6):1012 View
- Dezanet L, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy 2021;76(11):3009 View
- Wang C, Zhang S, Zhao J, Wang M, Lu Q, Liu B, Du J, Cui F. Changes and gaps of global and regional disease burden of hepatitis B infection in children younger than 5 years old between 2015 and 2019: A real‐world data review. Journal of Medical Virology 2023;95(11) View